ContractMira Pharmaceuticals, Inc. • July 14th, 2023 • Pharmaceutical preparations
THIS WARRANT AND THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT, AND UPON DELIVERY OF AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE SECURITIES ACT.
AGREEMENT FOR SHARED LEASE COSTSAgreement for Shared • July 14th, 2023 • Mira Pharmaceuticals, Inc. • Pharmaceutical preparations
This Agreement for Shared Lease Costs (the “Agreement”) is made, effective as of April 1, 2023 by and among MIRALOGX LLC. (“ MIRALOGX”), MIRA Pharmaceuticals, Inc. (“MIRA” ) and Telomir Pharmaceuticals, Inc. (“Telomir”), all with a mailing address of 900 West Platt Street, Suite 200, Tampa, Florida 33606.
Master Collaboration Agreement between The Johns Hopkins University and MIRA Pharmaceuticals, Inc.Master Collaboration Agreement • July 14th, 2023 • Mira Pharmaceuticals, Inc. • Pharmaceutical preparations • Maryland
This Collaboration Agreement (“Agreement”), effective on November 1st, 2021 (“Effective Date”), is entered into by and between The Johns Hopkins University on behalf of its School of Medicine (“JHU”), having an address at 733 N. Broadway, Suite 117, Baltimore, Maryland 21205, and MIRA Pharmaceuticals, Inc., (“MIRA”), a Florida corporation having its principal address at 324 South Hyde Park Ave., Suite 350, Tampa, Florida 33606 (individually a “Party” and collectively the “Parties”).
